PRECLINICAL GAP ANALYSIS
Comprehensive evaluation to identify and close critical gaps, ensuring readiness for clinical trials.
Customized Development Roadmaps
Detailed plans from preclinical stages through Phase III, including milestones and resource allocation.
Clinical Protocol Design
Tailored protocols focusing on endpoints and enrollment criteria with the highest success probabilities.
Clinical Advisory Board Formation
Establishment of advisory boards featuring leading KOLs for strategic guidance and credibility.
Strategic Endpoint Selection
Optimization of trial endpoints to ensure clinical relevance and statistical significance.
KOL and Trial Site Engagement
Access to top-tier Key Opinion Leaders and partnerships with premier trial sites for optimal trial execution.
Statistical Analysis Expertise
Utilization of world-leading statisticians to design and analyze trials with robust statistical power.
Regulatory Support
Expertise in preparing IND packages and meeting pharmaceutical evaluation standards.
Success-Based Clinical Development Model
Cost-effective strategies designed to align with your budget and maximize impact.
Data Delivery and Insights
Data Delivery and Insights
Provision of actionable, pharmaceutical-ready data that facilitates strategic alliances, including licensing and staged acquisitions.